patent semaglutide The for the key ingredient in Ozempic and Wegovy developed by Novo Nordisk is set to expire in India on March 20, opening the door for a wave of low-cost GLP-1 maker jumps on patent

Join the altRx community Your treatment is reviewed and guided by our on-staff licensed clinicians who understand weight loss at a clinical level, so you can move forward with confidence

2 Licensed provider review (2448 hours) A board-certified physician or NP reviews your intake

Join the growing group of patients who've successfully used GLP-1 weight loss medications by starting your journey with an online intake form

By understanding how the medication affects your body and implementing appropriate lifestyle changes, you can alleviate discomfort associated with this condition

This is an insatiable and lifelong hunger that begins when patients are around four years old